Case number 1:24-cv-00657
ViiV Healthcare Company et al v. Hetero USA, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 11, 2024 | 22 | REDACTED VERSION of 19 Stipulation by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 12/11/2024) (2) |
| Dec 11, 2024 | 23 | CONSENT JUDGMENT Signed by Judge Mitchell S. Goldberg on 12/11/2024. (CASE CLOSED) (mpb) (Entered: 12/11/2024) (3) |
| Dec 11, 2024 | 24 | FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (mpb) (Entered: 12/11/2024) (1) |
| Dec 9, 2024 | 21 | PROPOSED CONSENT JUDGMENT by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 12/09/2024) (3) |
| Dec 5, 2024 | 20 | ORDER: Upon consideration of the Parties' (Second) Joint Stipulation to Stay All Deadlines, it is hereby ORDERED that the Stipulation is GRANTED. No further stay requests will be granted absent exigent circumstances. It is FURTHER ORDERED that within 7 days of this Order, the Parties may submit amotion to seal addressing why under In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 924 F.3d 662, 672 (3d Cir. 2019), ECF Docs. 16, 17, and 19 should be sealed. Failure to submit such a brief will result in the documents being unsealed. Signed by Judge Mitchell S. Goldberg on 12/5/2024. (mpb) (Entered: 12/05/2024) (1) |
| Dec 4, 2024 | 19 | [SEALED] STIPULATION and [Proposed] Order to Stay All Deadlines Pending Dismissal by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 12/04/2024) (0) |
| Nov 27, 2024 | 18 | REDACTED VERSION of 16 Stipulation by ViiV Healthcare Company, Shionogi & Co., Ltd., ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 11/27/2024) (4) |
| Nov 21, 2024 | 17 | [SEALED] SO ORDERED, re 16 Stipulation filed by Hetero Labs Limited Unit-V, Hetero Labs Limited, Hetero USA, Inc. (CASE STAYED) Signed by Judge Mitchell S. Goldberg on 11/21/2024. This order has been emailed to local counsel. (mpb) (Entered: 11/22/2024) (0) |
| Nov 20, 2024 | 16 | [SEALED] STIPULATION to Stay pending Dismissal by Hetero USA, Inc., Hetero Labs Limited Unit-V, Hetero Labs Limited. (Hitch, Cortlan) (Entered: 11/20/2024) (0) |
| Oct 18, 2024 | 14 | STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to November 20, 2024 - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc.. (Dorsney, Kenneth) (Entered: 10/18/2024) (2) |
| Oct 18, 2024 | 15 | ORDER: The parties' Joint Stipulation for Extension of time to Answer Plaintiff's Complaint (D.I. 14 ) is GRANTED. Defendants' are to respond by November 20, 2024. No further extension requests will be granted absent exigent circumstances. Signed by Judge Mitchell S. Goldberg on 10/18/2024. (mpb) (Entered: 10/18/2024) (1) |
| Sep 27, 2024 | 13 | STIPULATION AND ORDER regarding D.I. 12 STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to October 21, 2024. Signed by Judge Mitchell S. Goldberg on 09/27/2024. (vfm) (Entered: 09/27/2024) (2) |
| Sep 20, 2024 | 12 | STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to October 21, 2024 - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc.. (Hitch, Cortlan) (Entered: 09/20/2024) (2) |
| Sep 5, 2024 | 11 | STIPULATION AND ORDER regarding D.I. 10 STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to September 20, 2024. Ordered by Judge Mitchell S. Goldberg on 09/05/2024. (vfm) (Entered: 09/05/2024) (2) |
| Aug 21, 2024 | 10 | STIPULATION TO EXTEND TIME for Hetero to Answer, Move or Otherwise Respond to the Complaint to September 20, 2024 - filed by Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc.. (Dorsney, Kenneth) (Entered: 08/21/2024) (2) |
| Aug 2, 2024 | 7 | DECLARATION of Service of Complaint and related papers on defendant Hetero Labs Limited Unit-V by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 08/02/2024) (2) |
| Aug 2, 2024 | 8 | DECLARATION of Service of Complaint and related papers on defendant Hetero Labs Limited by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 08/02/2024) (2) |
| Aug 2, 2024 | 9 | DECLARATION of Service of Complaint and related papers on defendant Hetero USA Inc. by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Joyce, Alexandra) (Entered: 08/02/2024) (2) |
| Jun 10, 2024 | N/A | Case Assigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania (due to related cases). Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) (Entered: 06/10/2024) (0) |
| Jun 3, 2024 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc. ( Filing fee $ 405, receipt number ADEDC-4421465.) - filed by ViiV Healthcare UK (No. 3) Limited, ViiV Healthcare Company, Shionogi & Co., Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (vfm) (Entered: 06/03/2024) (0) |
| Jun 3, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 06/03/2024) (3) |
| Jun 3, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 04/25/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 10/25/2026. (vfm) (Entered: 06/03/2024) (1) |
| Jun 3, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986. (vfm) (Entered: 06/03/2024) (1) |
| Jun 3, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (vfm) (Entered: 06/03/2024) (1) |
| Jun 3, 2024 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline plc., Corporate Parent Shionogi Limited, Other Affiliate The Bank of New York Mellon, Other Affiliate Shionogi & Co., Ltd. for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited - filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (vfm) (Entered: 06/03/2024) (2) |
| Jun 3, 2024 | N/A | No Summons Issued. (vfm) (Entered: 06/03/2024) (0) |
